UBS Group’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-177,500
Closed -$2.93M 9250
2023
Q4
$2.93M Buy
+177,500
New +$2.47M ﹤0.01% 3405
2022
Q2
Sell
-15,000
Closed -$156K 10263
2022
Q1
$156K Buy
+15,000
New +$203K ﹤0.01% 5557
2017
Q2
Sell
-360,000
Closed -$6.79M 7631
2017
Q1
$6.79M Buy
+360,000
New +$7.57M ﹤0.01% 1812
2015
Q3
Sell
-16,600
Closed -$276K 8378
2015
Q2
$276K Buy
16,600
+15,600
+1,560% +$368K ﹤0.01% 4592
2015
Q1
$24K Sell
1,000
-3,500
-78% -$89K ﹤0.01% 6778
2014
Q4
$110K Buy
+4,500
New +$105K ﹤0.01% 5605

Other funds holding OSG

UBS Group's OSG Position: Q2 2026 in Review

UBS Group reduced its Octave Specialty Group (OSG) stake by 44% in Q2 2026, selling an estimated $610K and leaving 147,197 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #5807.

UBS Group first reported a position in OSG in Q4 2014 and has held it in 47 quarters since. The position peaked at $13M in Q1 2023. 147 funds tracked by Wall St. Rank hold OSG as of Q2 2026.

  • UBS Group held 147,197 shares of Octave Specialty Group worth $919K as of Q2 2026.
  • UBS Group sold 117,083 Octave Specialty Group shares in Q2 2026, an estimated $610K.
  • Octave Specialty Group made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5807 holding.
  • UBS Group first reported a position in Octave Specialty Group in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Octave Specialty Group position peaked at $13M in Q1 2023.
  • 147 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.